Paeds SAQs · genetics-dysmorphology-and-metabolism
Amino-acid disorders including phenylketonuria and MSUD — formative SAQs
Formative SAQs on recognising the inherited amino-acid disorders (PKU, MSUD, tyrosinaemia type I, homocystinuria) on their metabolite and clinical signatures, delivering the acute 'switch off catabolism, clear the toxin' protocol for an MSUD crisis, and locking in long-term diet, cofactor and enzyme-substitution therapy with maternal PKU counselling.
On this page
Study tools
Target exams
SAQ 1 (10 marks)
A term male neonate is well at birth and on breast and formula feeds. At 72 hours of age he becomes lethargic, feeds poorly, vomits, and is found with opisthotonic posturing and intermittent dystonia. The nursing staff note a sweet, caramel-like smell to his urine. A blood gas shows a high anion-gap metabolic acidosis with ketosis; the ammonia is normal. [7] [8]
a) Explain why this picture of a well neonate deteriorating 48 to 120 hours into feeds with ketoacidosis and an odour is classic for maple syrup urine disease, and name the single most specific confirmatory metabolite. (3 marks) [7]
b) Outline the acute management, naming the four moves of the shared metabolic protocol and the rationale for supplementing isoleucine and valine while restricting leucine. (4 marks) [7] [8]
c) Describe the role of extracorporeal removal, including the leucine threshold or trajectory that would trigger it, and explain why outcome tracks time on the toxic metabolite. [7] (3 marks) [7]
References6ShowHide
- [1]Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet, 2010.PMID 20971365
- [2]van Wegberg AMJ, MacDonald A, Ahring K, et al. European guidelines on diagnosis and treatment of phenylketonuria: First revision. Mol Genet Metab, 2025.PMID 40378670
- [7]Strauss KA, Puffenberger EG, Carson VJ Maple Syrup Urine Disease. GeneReviews, 1993.PMID 20301495
- [8]Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab, 2014.PMID 24881969
- [10]Ficicioglu C Tyrosinemia Type I. GeneReviews, 1993.PMID 20301688
- [11]Sacharow SJ, Levy HL Homocystinuria due to Cystathionine Beta-Synthase Deficiency. GeneReviews, 1993.PMID 20301697